tetrabenazine has been researched along with Movement Disorders in 62 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 35 (56.45) | 18.7374 |
| 1990's | 3 (4.84) | 18.2507 |
| 2000's | 3 (4.84) | 29.6817 |
| 2010's | 18 (29.03) | 24.3611 |
| 2020's | 3 (4.84) | 2.80 |
| Authors | Studies |
|---|---|
| Bachoud-Levi, AC; Bentivoglio, AR; Burgunder, JM; Cardoso, F; Claassen, DO; Costa, J; Duarte, GS; Ferreira, JJ; Furr-Stimming, E; Kulisevsky, J; Landwehrmeyer, GB; Mestre, TA; Nirenberg, MJ; Rodrigues, FB; Rosser, A; Roth, J; Sampaio, C; Seppi, K; Slawek, J; Tabrizi, SJ; Vandenberghe, W; Walker, FO | 1 |
| Akbostanci, MC; Sahin, T; Yilmaz, R | 1 |
| Bhidayasiri, R; Caroff, SN; Correll, CU; Fahn, S; Frei, KP; Hauser, RA; Jankovic, J; Kane, JM; Truong, DD | 1 |
| Alstrup, AKO; Brooks, DJ; Doudet, DJ; Glud, AN; Landau, AM; Lillethorup, TP; Mikkelsen, TW; Nielsen, EH; Orlowski, D; Sørensen, JCH; Zaer, H | 1 |
| Jimenez-Shahed, J; Tarakad, A | 1 |
| Dinelle, K; Doudet, DJ; Flores, J; Jing, Y; Mackey, S | 1 |
| Armangue, T; Cantarín-Extremera, V; Duat-Rodríguez, A; González-Gutiérrez-Solana, L; López-Marín, L | 1 |
| Aschermann, Z; Horváth, K; Komoly, S; Kovács, A; Kovács, N | 1 |
| Aragones, JM; Blanch, CE; Escote-Llobet, S; Guillen-Font, A | 1 |
| Lerner, PP; Lerner, V; Miodownik, C | 1 |
| Altavilla, R; Arosio, C; di Biase, L; Frontali, M; Marano, M; Melgari, JM; Nuovo, S; Piperno, A; Quattrocchi, CC; Salomone, G; Scrascia, F; Siotto, M; Squitti, R; Vernieri, F | 1 |
| Burke, J; Castro-Gayol, JC; Factor, SA; Hauser, RA; Jimenez, R; Mandri, D; O'Brien, CF | 1 |
| Jankovic, J | 2 |
| Guay, DR | 1 |
| Breden, EL; Leung, JG | 1 |
| Franch, O; Kurtis, MM | 1 |
| Dobronevsky, E; Kimiagar, I; Miniovitz, A; Prokhorov, T; Rabey, JM | 1 |
| Akdeniz, M; Yaman, A; Yaman, H | 1 |
| Chen, JJ; Dashtipour, K; Ondo, WG; Swope, DM | 1 |
| Shprecher, D | 1 |
| Davidson, A; Hunter, C; Jankovic, J; Jimenez-Shahed, J; Mehanna, R | 1 |
| Cheminal, R; Echenne, B; Humbertclaude, V; Leydet, J; Rivier, F; Roubertie, A | 1 |
| Jankovic, J; Kenney, C | 1 |
| Andersson, DR; Bergquist, F; Nissbrandt, H | 1 |
| Lang, AE; Marsden, CD | 1 |
| Aminoff, MJ; Asher, SW | 1 |
| Bartels, M; Zeller, E | 1 |
| Dichgans, J; Schumm, F; Zeller, E | 1 |
| Beach, J; Jankovic, J | 1 |
| Corral, C; Darias, V; Expósito-Orta, MA; Lissavetzky, J; Manzanares, I; Martïn Conde, JA; Sánchez-Mateo, CC | 1 |
| Kingston, D | 1 |
| Koe, BK | 1 |
| Godwin-Austen, RB | 1 |
| Davidson, DL; Mawdsley, C; Pullar, IA; Wilson, H; Yates, CM | 1 |
| Clyne, KE; Juhl, R | 1 |
| Howell, SJ; Laing, RW | 1 |
| Butler, IJ; Caskey, TC; Jankovic, J; Stout, JT | 1 |
| Jankovic, J; Orman, J | 1 |
| Vieregge, P | 1 |
| Galloway, HM; McLean, S; Millingen, KS; Roberts, MS | 1 |
| Rasmussen, D | 1 |
| Martí-Massó, JF; Obeso, JA | 1 |
| Dalby, MA | 1 |
| Bachmann, T; Jurna, I; Theres, C | 1 |
| Fog, R; Pakkenberg, H | 2 |
| Heathfield, KW; Roberts, AH; Swash, M; Zakko, H | 1 |
| McLellan, DL | 1 |
| Gilligan, BS; Munro, OR; Veale, JL; Wodak, J | 1 |
| Marsden, CD | 1 |
| Chase, TN | 1 |
| Gordon, N | 1 |
| Andrews, TM; Brown, E; Griffiths, MI; McKeran, RO; Watts, RW | 1 |
| Chien, C; Cole, JO; Kazamatsuri, H | 2 |
| Chien, CP; Cole, JO; Kazamatsuri, H | 1 |
| Teusink, JP | 1 |
| Clark, T; Godwin-Austen, RB | 1 |
| Bergmann, S; Frears, CC; Godwin-Austen, RB | 1 |
| Pearce, J | 1 |
| MacCallum, WA | 1 |
13 review(s) available for tetrabenazine and Movement Disorders
| Article | Year |
|---|---|
An MDS Evidence-Based Review on Treatments for Huntington's Disease.
Topics: Apathy; Chorea; Humans; Huntington Disease; Movement Disorders; Tetrabenazine | 2022 |
Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool.
Topics: Antipsychotic Agents; Dyskinesias; Humans; Movement Disorders; Outcome Assessment, Health Care; Tardive Dyskinesia; Tetrabenazine | 2020 |
VMAT2 Inhibitors in Neuropsychiatric Disorders.
Topics: Antipsychotic Agents; Basal Ganglia; Humans; Mental Disorders; Movement Disorders; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins | 2018 |
[Treatment of tardive syndromes].
Topics: Amantadine; Antipsychotic Agents; Botulinum Toxins; Central Nervous System Agents; Cholinergic Antagonists; Clinical Trials as Topic; Clonazepam; Deep Brain Stimulation; Dopamine Antagonists; Ginkgo biloba; Humans; Levetiracetam; Movement Disorders; Nootropic Agents; Piracetam; Primary Prevention; Propranolol; Syndrome; Tetrabenazine; Vitamin E | 2014 |
Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; alpha-Tocopherol; Amantadine; Anticonvulsants; Antioxidants; Antipsychotic Agents; Clonazepam; Dopamine Agents; Drugs, Chinese Herbal; Fatty Acids, Omega-3; Ginkgo biloba; Humans; Isoleucine; Isoxazoles; Leucine; Levetiracetam; Melatonin; Movement Disorders; Nootropic Agents; Piracetam; Plant Extracts; Propranolol; Pyridoxine; Resveratrol; Stilbenes; Tetrabenazine; Valine; Vitamins; Zonisamide | 2015 |
Dopamine depleters in the treatment of hyperkinetic movement disorders.
Topics: Animals; Antipsychotic Agents; Dopamine; Dopamine Antagonists; Humans; Huntington Disease; Hyperkinesis; Movement Disorders; Receptors, Dopamine; Tardive Dyskinesia; Tetrabenazine; Tics; Treatment Outcome | 2016 |
Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Cytochrome P-450 CYP2D6; Depression; Dopamine; Drug Interactions; Genotype; Humans; Huntington Disease; Hyperkinesis; Middle Aged; Movement Disorders; Neuroleptic Malignant Syndrome; Parkinson Disease, Secondary; Quinolizines; Reserpine; Serotonin; Tetrabenazine; Vesicular Monoamine Transport Proteins; Young Adult | 2010 |
Tetrabenazine for the treatment of tardive dyskinesia.
Topics: Adrenergic Uptake Inhibitors; Clinical Trials as Topic; Humans; Movement Disorders; Prospective Studies; Tetrabenazine | 2011 |
How best to address these common movement disorders.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Anticonvulsants; Antiparkinson Agents; Essential Tremor; Humans; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Parkinson Disease; Practice Guidelines as Topic; Primidone; Propranolol; Tetrabenazine; Tourette Syndrome; Treatment Outcome | 2011 |
Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
Topics: Adrenergic Uptake Inhibitors; Animals; Chorea; Dystonia; Humans; Huntington Disease; Hyperkinesis; Movement Disorders; Rare Diseases; Tetrabenazine; Tic Disorders | 2012 |
[Movement disorders in childhood: therapeutic update].
Topics: Anti-Dyskinesia Agents; Baclofen; Botulinum Toxins, Type A; Child; Consensus; Electric Stimulation Therapy; Globus Pallidus; Humans; Movement Disorders; Muscle Relaxants, Central; Neuromuscular Agents; Patient Selection; Pediatrics; Practice Guidelines as Topic; Research Design; Tetrabenazine; Treatment Outcome | 2004 |
Tetrabenazine in the treatment of hyperkinetic movement disorders.
Topics: Adrenergic Uptake Inhibitors; Clinical Trials as Topic; Drug Tolerance; Expert Testimony; Humans; Huntington Disease; Hyperkinesis; Movement Disorders; Tetrabenazine | 2006 |
Drug-induced extrapyramidal disorders.
Topics: Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Benztropine; Dihydroxyphenylalanine; Dopamine; Drug-Related Side Effects and Adverse Reactions; Extrapyramidal Tracts; Haloperidol; Humans; Methyltyrosines; Movement Disorders; Phenothiazines; Phenylacetates; Probenecid; Reserpine; Synaptic Transmission; Tetrabenazine; Tranquilizing Agents; Trihexyphenidyl | 1972 |
10 trial(s) available for tetrabenazine and Movement Disorders
| Article | Year |
|---|---|
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Severity of Illness Index; Tetrabenazine; Treatment Outcome; Valine; Vesicular Biogenic Amine Transport Proteins; Young Adult | 2015 |
Tetrabenazine and movement disorders.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Tetrabenazine | 1981 |
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
Topics: Chorea; Clinical Trials as Topic; Drug Synergism; Dystonia; Humans; Lithium; Middle Aged; Movement Disorders; Nervous System Diseases; Parkinson Disease, Secondary; Tetrabenazine; Tic Disorders | 1988 |
Tetrabenazine in the treatment of extrapyramidal dyskinesias.
Topics: Adolescent; Adult; Athetosis; Basal Ganglia Diseases; Chorea; Clinical Trials as Topic; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Placebos; Spasm; Tetrabenazine | 1972 |
Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
Topics: Adult; Aged; Basal Ganglia Diseases; Brain Chemistry; Clinical Trials as Topic; Dopamine; Evaluation Studies as Topic; Female; Haloperidol; Humans; Male; Mental Disorders; Middle Aged; Movement Disorders; Phenothiazines; Piperazines; Placebos; Tetrabenazine; Tranquilizing Agents | 1972 |
Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.
Topics: Adult; Aged; Basal Ganglia; Basal Ganglia Diseases; Brain Chemistry; Clinical Trials as Topic; Dopamine; Evaluation Studies as Topic; Female; Humans; Male; Mental Disorders; Middle Aged; Mouth; Movement Disorders; Placebos; Tetrabenazine; Time Factors; Tranquilizing Agents | 1972 |
Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine.
Topics: Adult; Basal Ganglia Diseases; Clinical Trials as Topic; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Haloperidol; Humans; Length of Stay; Male; Mental Disorders; Middle Aged; Movement Disorders; Placebos; Recurrence; Remission, Spontaneous; Substance Withdrawal Syndrome; Tetrabenazine; Time Factors; Tranquilizing Agents | 1973 |
Spontaneous oral dyskinesia. Results of treatment with tetrabenazine, pimozide, or both.
Topics: Aged; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Mouth Diseases; Movement Disorders; Parkinson Disease, Secondary; Pimozide; Remission, Spontaneous; Salivary Gland Diseases; Tetrabenazine; Time Factors | 1974 |
Persistent phenothiazine dyskinesia treated with tetrabenazine.
Topics: Aged; Chlorpromazine; Clinical Trials as Topic; Diazepam; Facial Expression; Humans; Male; Movement Disorders; Phenothiazines; Tetrabenazine; Trifluoperazine | 1971 |
Effect of age and arteriosclerosis on the response of Parkinsonian patients to levodopa.
Topics: Age Factors; Aged; Antiemetics; Arteriosclerosis; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; Hallucinations; Humans; Hypotension, Orthostatic; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Tetrabenazine; Vomiting | 1971 |
39 other study(ies) available for tetrabenazine and Movement Disorders
| Article | Year |
|---|---|
Predictive factors for tolerability of tetrabenazine in patients with hyperkinetic movement disorders.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Chorea; Drug-Related Side Effects and Adverse Reactions; Dystonic Disorders; Female; Humans; Hyperkinesis; Male; Middle Aged; Movement Disorders; Parkinson Disease, Secondary; Tardive Dyskinesia; Tetrabenazine; Tic Disorders; Turkey; Young Adult | 2020 |
Nigrostriatal proteasome inhibition impairs dopamine neurotransmission and motor function in minipigs.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopamine; HLA-DR Antigens; Magnetic Resonance Imaging; Movement Disorders; Positron-Emission Tomography; Substantia Nigra; Swine; Swine, Miniature; Synaptic Transmission; Tetrabenazine; Tyrosine 3-Monooxygenase | 2018 |
Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: behavior, positron emission tomography, immunohistochemistry.
Topics: Acetylcysteine; Analysis of Variance; Animals; Carbon Isotopes; Cell Count; Corpus Striatum; Cysteine Proteinase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Functional Laterality; Hindlimb; Locomotion; Movement Disorders; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tetrabenazine; Time Factors; Tyrosine 3-Monooxygenase | 2013 |
Clinical case of anti-N-methyl-D-aspartate receptor encephalitis in an 8-month-old patient with hyperkinetic movement disorder.
Topics: Anti-Dyskinesia Agents; Anti-Inflammatory Agents; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Deglutition Disorders; Humans; Hyperkinesis; Immunoglobulins, Intravenous; Infant; Male; Methylprednisolone; Movement Disorders; Prednisone; Psychomotor Agitation; Stupor; Tetrabenazine; Treatment Outcome | 2013 |
[Buccolingual dyskinesia with justified hallucinations].
Topics: Alcoholism; Benzodiazepines; Clonazepam; Depressive Disorder; Dibenzothiazepines; Disulfiram; Female; Fluoxetine; Foreign Bodies; Hallucinations; Humans; Middle Aged; Movement Disorders; Olanzapine; Pharynx; Quetiapine Fumarate; Tetrabenazine; Tongue Habits | 2014 |
Movement disorders and brain iron overload in a new subtype of aceruloplasminemia.
Topics: Adrenergic Uptake Inhibitors; Brain; Ceruloplasmin; Chorea; Diagnosis, Differential; Dystonia; Female; Humans; Iron Metabolism Disorders; Iron Overload; Middle Aged; Movement Disorders; Neurodegenerative Diseases; Tetrabenazine; Treatment Outcome | 2015 |
Tardive syndrome and Parkinson's disease responsive to concomitant tetrabenazine and levodopa therapy.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Depression; Female; Flupenthixol; Humans; Levodopa; Movement Disorders; Parkinson Disease; Tetrabenazine | 2011 |
Rapid improvement of tardive dyskinesia with tetrabenazine, clonazepam and clozapine combined: a naturalistic long-term follow-up study.
Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Clonazepam; Clozapine; Drug Therapy, Combination; Female; Follow-Up Studies; GABA Modulators; Humans; Male; Middle Aged; Movement Disorders; Psychotic Disorders; Retrospective Studies; Tetrabenazine; Young Adult | 2012 |
Sensory trick with metoclopramide-associated tardive tremor.
Topics: Adrenergic Uptake Inhibitors; Aged; Blepharospasm; Cervical Vertebrae; Dopamine Antagonists; Humans; Male; Manipulation, Osteopathic; Metoclopramide; Movement Disorders; Neck; Pressure; Spinal Stenosis; Tetrabenazine; Tremor | 2012 |
Analysis of CYP2D6 genotype and response to tetrabenazine.
Topics: Adult; Anti-Dyskinesia Agents; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Huntington Disease; Hyperkinesis; Male; Middle Aged; Movement Disorders; Myoclonus; Pharmacogenetics; Phenotype; Psychomotor Agitation; Tetrabenazine; Tourette Syndrome; Treatment Outcome | 2013 |
Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission.
Topics: Adrenergic Uptake Inhibitors; Animals; Corpus Striatum; Dendrites; Disease Models, Animal; Dopamine; Extracellular Fluid; Female; Motor Activity; Movement; Movement Disorders; Neural Pathways; Parkinsonian Disorders; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Substantia Nigra; Synaptic Transmission; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2006 |
Alpha methylparatyrosine and tetrabenazine in movement disorders.
Topics: Adult; alpha-Methyltyrosine; Chorea; Drug Therapy, Combination; Dystonia; Female; Humans; Male; Methyltyrosines; Middle Aged; Movement Disorders; Tetrabenazine; Tyrosine 3-Monooxygenase | 1982 |
Tetrabenazine (Nitoman) therapy of chronic spontaneous oral dyskinesia. A video- and EMG-controlled study.
Topics: Aged; Dose-Response Relationship, Drug; Electromyography; Facial Muscles; Female; Humans; Male; Masticatory Muscles; Middle Aged; Movement Disorders; Muscle Tonus; Tetrabenazine | 1984 |
Tetrabenazine in the treatment of hyperkinetic movement disorders.
Topics: Adolescent; Adult; Aged; Child; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Hyperkinesis; Male; Middle Aged; Movement Disorders; Myoclonus; Outcome and Process Assessment, Health Care; Syndrome; Tetrabenazine; Tourette Syndrome | 1983 |
[Spontaneous oral dyskinesia. Successful treatment with tetrabenazine (author's transl)].
Topics: Aged; Basal Ganglia Diseases; Blepharospasm; Dose-Response Relationship, Drug; Female; Humans; Male; Masticatory Muscles; Movement Disorders; Receptors, Dopamine; Tetrabenazine | 1981 |
Long-term effects of tetrabenazine in hyperkinetic movement disorders.
Topics: Adult; Anti-Dyskinesia Agents; Child; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Movement Disorders; Randomized Controlled Trials as Topic; Tetrabenazine | 1997 |
Synthesis and preliminary pharmacological evaluation of thiophene analogues of viloxazine as potential antidepressant drugs.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Apomorphine; Blepharoptosis; Dose-Response Relationship, Drug; Female; Hypothermia; Imipramine; Lethal Dose 50; Male; Mice; Movement Disorders; Pentobarbital; Sleep; Structure-Activity Relationship; Tetrabenazine; Viloxazine | 1999 |
Tetrabenazine for involuntary movement disorders.
Topics: Humans; Huntington Disease; Middle Aged; Movement Disorders; Tetrabenazine | 1979 |
Monoamine oxidase inhibitors antagonize the acceleration of brain dopamine synthesis induced by neuroleptic drugs in vivo: implications for the treatment of Tardive dyskinesia.
Topics: Animals; Brain; Corpus Striatum; Dopamine; Hydrazines; Male; Monoamine Oxidase Inhibitors; Movement Disorders; Pargyline; Rats; Tetrabenazine; Tranquilizing Agents; Trifluoperazine | 1975 |
The treatment of the choreas and athetotic dystonias.
Topics: Adult; Athetosis; Benzodiazepines; Child; Chorea; Dystonia; Haloperidol; Humans; Levodopa; Movement Disorders; Phenelzine; Phenothiazines; Pimozide; Tetrabenazine; Valproic Acid | 1979 |
CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Serotonin; Tetrabenazine; Torticollis | 1977 |
Tardive dyskinesia.
Topics: Choline; Deanol; Dopamine Antagonists; Haloperidol; Humans; Methyldopa; Movement Disorders; Papaverine; Parasympathomimetics; Reserpine; Tetrabenazine | 1976 |
Acute bilateral ballism in a patient with intravascular dissemination of gastric carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bronchopneumonia; Chlorpromazine; Female; Humans; Movement Disorders; Stomach Neoplasms; Tetrabenazine | 1992 |
Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters.
Topics: Carbidopa; Catecholamines; Child; Child, Preschool; Fluphenazine; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Lesch-Nyhan Syndrome; Levodopa; Male; Methoxyhydroxyphenylglycol; Movement Disorders; Self Mutilation; Tetrabenazine | 1988 |
Tetrabenazine in the treatment of senile vocal tics.
Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Humans; Movement Disorders; Tetrabenazine; Tic Disorders; Tourette Syndrome; Voice Disorders | 1987 |
The pharmacokinetics of tetrabenazine and its hydroxy metabolite in patients treated for involuntary movement disorders.
Topics: Blood Proteins; Humans; Injections, Intravenous; Kinetics; Movement Disorders; Protein Binding; Tetrabenazine | 1986 |
[Hemiballism].
Topics: Aged; Cerebrovascular Disorders; Female; Haloperidol; Humans; Male; Middle Aged; Movement Disorders; Tetrabenazine | 1986 |
Coprolalia associated with hemiballismus: response to tetrabenazine.
Topics: Aged; Basal Ganglia; Cerebrovascular Disorders; Humans; Male; Movement Disorders; Speech Disorders; Tetrabenazine | 1985 |
Effect of tetrabenazine on extrapyramidal movement disorders.
Topics: Chorea; Extrapyramidal Tracts; Female; Humans; Huntington Disease; Male; Movement Disorders; Parkinson Disease; Tetrabenazine | 1969 |
The effect of physostigmine and tetrabenazine on spinal motor control and its inhibition by drugs which influence reserpine rigidity.
Topics: 1-Propanol; Animals; Atropine; Biperiden; Dihydroxyphenylalanine; Electric Stimulation; Electromyography; Methamphetamine; Motor Neurons; Movement Disorders; Parasympatholytics; Phenytoin; Physostigmine; Piperidines; Rats; Reserpine; Spinal Cord; Spinal Nerves; Tetrabenazine; Trihexyphenidyl | 1969 |
Combined nitoman-pimozide treatment of Huntington's chorea and other hyperkinetic syndromes.
Topics: Humans; Huntington Disease; Movement Disorders; Tetrabenazine; Tranquilizing Agents | 1970 |
Treatment of involuntary movement disorders with tetrabenazine.
Topics: Adolescent; Adult; Aged; Amantadine; Child; Depression; Dystonia Musculorum Deformans; Evaluation Studies as Topic; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Sleep Initiation and Maintenance Disorders; Tetrabenazine; Torticollis | 1972 |
The suppression of involuntary movements with tetrabenazine.
Topics: Adolescent; Adult; Aged; Ataxia; Athetosis; Depression; Diencephalon; Evaluation Studies as Topic; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Tetrabenazine; Time Factors; Tremor | 1972 |
Drug treatment of diseases characterized by abnormal movements.
Topics: Chorea; Diazepam; Ethanol; Haloperidol; Humans; Huntington Disease; Levodopa; Movement Disorders; Myoclonus; Phenothiazines; Propranolol; Reserpine; Tetrabenazine; Tic Disorders; Torticollis; Tourette Syndrome; Tremor | 1973 |
Drugs and motor functions.
Topics: Athetosis; Catecholamines; Cholinesterase Inhibitors; Chorea; Dihydroxyphenylalanine; Dopamine; Extrapyramidal Tracts; Histamine H1 Antagonists; Humans; Motor Activity; Movement Disorders; Parkinson Disease; Phenothiazines; Reserpine; Tetrabenazine | 1971 |
Clinical and biochemical studies on treatment of Lesch-Nyhan syndrome.
Topics: Adenine; Allopurinol; Body Weight; Child, Preschool; Chlorpromazine; Creatinine; Exchange Transfusion, Whole Blood; Humans; Language Development; Lesch-Nyhan Syndrome; Male; Motor Skills; Movement Disorders; Pedigree; Pentosyltransferases; Phenothiazines; Tetrabenazine; Uric Acid | 1974 |
Tardive dyskinesia.
Topics: Adult; Anxiety; Chlorpromazine; Humans; Meprobamate; Movement Disorders; Neurologic Examination; Phenothiazines; Tetrabenazine | 1974 |
Reversal of hemiballismus by tetrabenazine.
Topics: Aged; Female; Humans; Movement Disorders; Tetrabenazine | 1972 |
Tetrabenazine for extra-pyramidal movement disorders.
Topics: Extrapyramidal Tracts; Female; Humans; Middle Aged; Movement Disorders; Phenothiazines; Tetrabenazine | 1970 |